June 23 - "Our reputation among our patients makes us proud because it is the tangible recognition that we deliver top quality drugs and services. Our patients are the center of our work and we do our best to keep them informed, aware and responsible." This enthusiastic comment comes from Lucia Aleotti, president of the Menarini Group. The Italian pharmaceutical company ranked in the top 10 worldwide for customer care. In particular, Menarini is 37^th of 19,042 companies for sales, but it’s 4^th for its ability to put the patient and her needs first, and 6^th for high quality of information provided to patients. The ranking was carried out by an independent study conducted on 800 patients from Patient View, a British organization that works closely with patient groups to make their voices heard. Patient View compiled the ranking of pharmaceutical companies that are more "patient friendly." According to the results, which involved groups of patients with different pathologies in 43 countries around the world, Menarini is one of the top 10 pharma companies attentive to the needs of the patient, and it is also one of the three companies that distinguished themselves for scoring the highest progress in the overall standings over the previous year. Menarini took an 11 position leap forward, from 19^th to 8^th in the global ranking. Ranking higher, there are the big international pharma companies such as ViiV, Gilead, AbbVie, Pfizer, Janssen, Roche, and Eli Lilly. (Red)

THE MENARINI GROUP

The Menarini Group, with more than 16.600 employees worldwide, operates in more than 100 countries in Europe, Asia, Latin America, Africa and the Middle East. In 2013, the turnover amounted to € 3.29 billion, with research and internationalization being main areas of strategic development for the future. The Group has 14 manufacturing facilities in Italy and abroad that produce over 562 million units per year.